Scarica l'app Stockscreener
0.00
100.00%
-3.65
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVNC Giù?
Forum
Previsione
Revance Therapeutics Inc Borsa (RVNC) Ultime notizie
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Two Sigma Investments LP Acquires 13,539 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Ameriprise Financial Inc. Raises Stock Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Investor Network: Revance Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
BNP Paribas Financial Markets Sells 10,728 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Deutsche Bank AG Grows Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Jane Street Group LLC Sells 491,504 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
ProShare Advisors LLC Increases Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Revance Therapeutics, Inc. (NASDAQ:RVNC) Given Consensus Rating of “Hold” by Brokerages - Defense World
Millennium Management LLC Increases Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Revance Announces Blue Lizard® Australian Sunscreen Times Square Takeover to Celebrate National Sunscreen Day - The Malaysian Reserve
The Gross Law Firm Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – RVNC - Louisiana First News
Northern Trust Corp Has $3.01 Million Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at Wall Street Zen - Defense World
Revance Names New CEO to Drive Next Phase in Aesthetic Innovation - Global Cosmetics News
Revance Announces Blue Lizard Australian Sunscreen® Partnership with The Bentway for Their Summer 2025 Sun/Shade Program - The Malaysian Reserve
Revance Announces Leadership Succession Plan to Support Next Phase of Growth and Innovation - Longview News-Journal
Price T Rowe Associates Inc. MD Purchases 7,839 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - ACCESS Newswire
Dermata Therapeutics, Inc. SEC 10-Q Report - TradingView
Revolutionary Once-Weekly Natural Acne Treatment Achieves Breakthrough in Phase 3 Trial Results - Stock Titan
Revance Therapeutics (NASDAQ:RVNC) Now Covered by StockNews.com - Defense World
Hsbc Holdings PLC Cuts Stock Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Lost Money on Revance Therapeutics, Inc. (RVNC)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Shareholders that Lost Money on Revance Therapeutics, Inc. (RVNC) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Revance Therapeutics, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Acquired by Wells Fargo & Company MN - Defense World
Revance Therapeutics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationRVNC - ACCESS Newswire
MetLife Investment Management LLC Has $184,000 Stock Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) PT at $8.39 - Defense World
Invesco Ltd. Boosts Holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Revance Therapeutics (NASDAQ:RVNC) Earns Hold Rating from Analysts at StockNews.com - Defense World
Spasticity Market Predicted to See Upsurge Through 2032, Highlights DelveInsight | Jazz Pharmaceuticals, Revance Therapeutics, Ipsen - Barchart.com
Press Release Distribution & PR Platform - ACCESS Newswire
Revance Therapeutics, Inc. (NASDAQ:RVNC) Shares Sold by LPL Financial LLC - Defense World
Revance Announces Blue Lizard® Australian Sunscreen Named the #1 Selling Mineral Sunscreen Brand - StreetInsider
Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at StockNews.com - Defense World
Levi & Korsinsky Notifies Revance Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineRVNC - ACCESS Newswire
Geode Capital Management LLC Raises Position in Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
Investigation announced for Long-Term Investors in Revance - openPR.com
Who’s Hired? Botox Biosimilar Developer Aeon Takes CEO From Rival Revance - insights.citeline.com
JPMorgan Chase & Co. Sells 2,335,359 Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC) - Defense World
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):